Scientific Online Resource System

Conference Proceedings

Fatty Liver Degeneration In Children: Association With Obstructive Sleep Apnea

Mihail Siromahov, N. Rasheva, K. Koleva, M. Georgieva

Abstract

Fatty liver degeneration, also termed hepatic steatosis, is a condition in which lipids accumulate in the hepatocytes causing cellular dysfunction and eventually cell death. Hepatic steatosis is diagnosed histologically when liver fat exceeds more than 5% of the liver weight. In adults, fatty liver degeneration is typically associated with excessive alcohol intake as in alcoholic fatty liver disease or with sedentary lifestyle and high-calorie diet as in non-alcoholic fatty liver disease (NAFLD). With the rise of obesity in recent decades, fatty liver disease has become the leading cause of chronic liver disease, not only in adults but in children as well. Besides liver disease, obesity is associated with several conditions among which is obstructive sleep apnea.

The aim of this article is to review the pathogenesis of fatty liver degeneration focusing on NAFLD and its relationship with obstructive sleep apnea in children.

Keywords

pediatric fatty liver, pathogenesis, obstructive sleep apnea

Full Text


References

Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN hepatology committee. J Pediatr Gastroenterol Nutr. 2012;54(5):700–13.

Kleiner DE. Histopathology, grading and staging of nonalcoholic fatty liver disease. Vol. 64, Minerva Gastroenterologica e Dietologica. Edizioni Minerva Medica; 2018. p. 28–38.

Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nu. J Pediatr Gastroenterol Nutr. 2017;64(2):319–34.

Hegarty R, Deheragoda M, Fitzpatrick E, Dhawan A. Paediatric fatty liver disease (PeFLD): All is not NAFLD – Pathophysiological insights and approach to management. J Hepatol [Internet]. 2018 Jun;68(6):1286–99. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168827818301235

Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Vol. 5, Therapeutic Advances in Gastroenterology. 2012. p. 199–207.

Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics [Internet]. 2006 Oct 1 [cited 2019 May 27];118(4):1388–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17015527

Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among united states adolescents, 1988-1994 to 2007-2010. J Pediatr [Internet]. 2013;162(3):496-500.e1. Available from: http://dx.doi.org/10.1016/j.jpeds.2012.08.043

Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model.” World J Gastroenterol. 2018;24(27):2974–83.

Polyzos S, Kountouras J, Zavos C. Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines. Curr Mol Med [Internet]. 2009 Apr 1;9(3):299–314. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1566-5240&volume=9&issue=3&spage=299

Jaeschke H. Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives. J Clin Transl Res [Internet]. 2018;4(1):75–100. Available from: http://www.jctres.com/en/04.201801.005/

Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Liver Physiol [Internet]. 2007 Oct;293(4):G871–7. Available from: https://www.physiology.org/doi/10.1152/ajpgi.00145.2007

Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol. 2007 Feb;102(2):557–63.

Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.[Erratum appears in Am J Respir Crit Care Med. 2009 Nov 1;180(9):910-1]. Am J Respir Crit Care Med [Internet]. 2009 [cited 2020 May 19];179(3):228–34. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medc&AN=18990675

Nobili V, Cutrera R, Liccardo D, Pavone M, Devito R, Giorgio V, et al. OSAS affects liver histology and inflammatory cell activation in paediatric NAFLD, regardless of obesity/insulin resistance. Am J Respir Crit Care Med. 2013 Nov 20;131120192008005.

Sundaram SS, Halbower A, Pan Z, Robbins K, Capocelli KE, Klawitter J, et al. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol [Internet]. 2016;65(3):560–9. Available from: http://dx.doi.org/10.1016/j.jhep.2016.04.010

Kheirandish-Gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest [Internet]. 2008;133(1):92–9. Available from: http://dx.doi.org/10.1378/chest.07-0773

Sundaram SS, Halbower AC, Klawitter J, Pan Z, Robbins K, Capocelli KE, et al. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children. J Pediatr [Internet]. 2018;198:67-75.e1. Available from: https://doi.org/10.1016/j.jpeds.2018.03.028


Refbacks

Font Size